Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Recruiting N/A Interventional Study
Breast Cancer Breast Cancer Female
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 59
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
46 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer in women with dense breast tissue by studying changes that occur in breast tissue and blood as a result of participating in an exercise program. The names of the study groups in this study are: * Exercise Training Group * Waitlist Control Group

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women aged 18-59 * Heterogeneously dense/extremely dense (BIRADS 3 or 4) breast tissue on mammogram within the past 12 months * Physically inactive; engaging in \<60 minutes of moderate or vigorous intensity exercise per week, as assessed by Godin Leisure Time screener * Not p…
Contacts

Jennifer Ligibel, MD

617-632-3800

jennifer_ligibel@dfci.harvard.edu

CONTACT

Anna Tanasijevic, MPH

617-632-5584

anna_tanasijevic@dfci.harvard.edu

CONTACT